Enhanced Microbial Bile Acid Deconjugation and Impaired Ileal Uptake in Pregnancy Repress Intestinal Regulation of Bile Acid Synthesis.


Journal

Hepatology (Baltimore, Md.)
ISSN: 1527-3350
Titre abrégé: Hepatology
Pays: United States
ID NLM: 8302946

Informations de publication

Date de publication:
07 2019
Historique:
received: 07 06 2018
accepted: 28 02 2019
pubmed: 16 4 2019
medline: 23 6 2020
entrez: 16 4 2019
Statut: ppublish

Résumé

Pregnancy is associated with progressive hypercholanemia, hypercholesterolemia, and hypertriglyceridemia, which can result in metabolic disease in susceptible women. Gut signals modify hepatic homeostatic pathways, linking intestinal content to metabolic activity. We sought to identify whether enteric endocrine signals contribute to raised serum bile acids observed in human and murine pregnancies, by measuring fibroblast growth factor (FGF) 19/15 protein and mRNA levels, and 7α-hydroxy-4-cholesten-3-one. Terminal ileal farnesoid X receptor (FXR)-mediated gene expression and apical sodium bile acid transporter (ASBT) protein concentration were measured by qPCR and western blotting. Shotgun whole-genome sequencing and ultra-performance liquid chromatography tandem mass spectrometry were used to determine the cecal microbiome and metabonome. Targeted and untargeted pathway analyses were performed to predict the systemic effects of the altered metagenome and metabolite profiles. Dietary CA supplementation was used to determine whether the observed alterations could be overcome by intestinal bile acids functioning as FXR agonists. Human and murine pregnancy were associated with reduced intestinal FXR signaling, with lower FGF19/15 and resultant increased hepatic bile acid synthesis. Terminal ileal ASBT protein was reduced in murine pregnancy. Cecal bile acid conjugation was reduced in pregnancy because of elevated bile salt hydrolase-producing Bacteroidetes. CA supplementation induced intestinal FXR signaling, which was not abrogated by pregnancy, with strikingly similar changes to the microbiota and metabonome as identified in pregnancy. Conclusion: The altered intestinal microbiota of pregnancy enhance bile acid deconjugation, reducing ileal bile acid uptake and lowering FXR induction in enterocytes. This exacerbates the effects mediated by reduced bile acid uptake transporters in pregnancy. Thus, in pregnant women and mice, there is reduced FGF19/15-mediated hepatic repression of hepatic bile acid synthesis, resulting in hypercholanemia.

Identifiants

pubmed: 30983011
doi: 10.1002/hep.30661
pmc: PMC6619257
doi:

Substances chimiques

Cholic Acids 0
Receptors, Cytoplasmic and Nuclear 0
farnesoid X-activated receptor 0C5V0MRU6P
Amidohydrolases EC 3.5.-
choloylglycine hydrolase EC 3.5.1.24

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

276-293

Subventions

Organisme : Tommy's Baby Charity
Pays : International
Organisme : Imperial College Healthcare NHS Trust
Pays : International
Organisme : Wellcome Trust
ID : P30874
Pays : United Kingdom
Organisme : King's College London
Pays : International
Organisme : NIHR Imperial Biomedical Research Centre
Pays : International
Organisme : Genesis Research Trust
Pays : International
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London
Pays : International
Organisme : National Institute for Health Research Biomedical Research Centres at Guy's and St Thomas' NHS Foundation Trust
Pays : International
Organisme : ICP Support
Pays : International
Organisme : Tommy's
Pays : International

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2019 The Authors. Hepatology published by Wiley Periodicals, Inc., on behalf of American Association for the Study of Liver Diseases.

Références

Science. 1999 May 21;284(5418):1365-8
pubmed: 10334993
Clin Sci (Lond). 2002 May;102(5):587-93
pubmed: 11980579
Gastroenterology. 2002 May;122(5):1483-92
pubmed: 11984532
Antimicrob Agents Chemother. 1992 Dec;36(12):2729-35
pubmed: 1482140
Mol Cell Proteomics. 2004 Jul;3(7):692-703
pubmed: 15073272
FEMS Microbiol Rev. 2005 Sep;29(4):625-51
pubmed: 16102595
Cell Metab. 2005 Oct;2(4):217-25
pubmed: 16213224
J Lipid Res. 2006 Jan;47(1):201-14
pubmed: 16251721
Obstet Gynecol. 2006 Jan;107(1):106-14
pubmed: 16394047
Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3920-5
pubmed: 16473946
Naunyn Schmiedebergs Arch Pharmacol. 2006 Mar;372(6):413-31
pubmed: 16541252
Am J Physiol Gastrointest Liver Physiol. 2008 Nov;295(5):G996-G1003
pubmed: 18772362
Am J Clin Nutr. 2008 Oct;88(4):894-9
pubmed: 18842773
Clin Gastroenterol Hepatol. 2009 Nov;7(11):1189-94
pubmed: 19426836
Am J Physiol Gastrointest Liver Physiol. 2010 Feb;298(2):G151-8
pubmed: 19815629
Eur J Endocrinol. 2010 May;162(5):897-903
pubmed: 20194524
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4523-30
pubmed: 20837534
Hepatology. 2010 Oct;52(4):1341-9
pubmed: 20842631
FEMS Microbiol Lett. 2011 May;318(1):68-75
pubmed: 21306429
Br J Pharmacol. 2012 Jan;165(2):414-23
pubmed: 21718300
Gastroenterology. 2011 Nov;141(5):1773-81
pubmed: 21839040
Bioinformatics. 2012 Jun 1;28(11):1420-8
pubmed: 22495754
Nature. 2012 Jul 5;487(7405):104-8
pubmed: 22722865
Cell. 2012 Aug 3;150(3):470-80
pubmed: 22863002
Hepatology. 2013 Feb;57(2):716-26
pubmed: 22961653
PLoS One. 2012;7(12):e49965
pubmed: 23226503
Cell Metab. 2013 Feb 5;17(2):225-35
pubmed: 23395169
Nucleic Acids Res. 2014 Jan;42(Database issue):D600-6
pubmed: 24165880
J Steroid Biochem Mol Biol. 2014 Mar;140:17-25
pubmed: 24189541
Hepatology. 2014 Dec;60(6):1993-2007
pubmed: 24729004
Steroids. 2014 Aug;86:62-8
pubmed: 24819989
Proc Natl Acad Sci U S A. 2015 Sep 1;112(35):11060-5
pubmed: 26283357
Gut Microbes. 2015;6(5):310-20
pubmed: 26322500
Hepatology. 2016 Apr;63(4):1287-98
pubmed: 26426865
Cell Metab. 2016 Jul 12;24(1):41-50
pubmed: 27320064
Toxicol Appl Pharmacol. 2016 Nov 1;310:60-67
pubmed: 27609522
FASEB J. 2017 Apr;31(4):1698-1708
pubmed: 28082353
J Lipid Res. 2017 Jun;58(6):1143-1152
pubmed: 28404640
J Gen Microbiol. 1967 Jan;46(1):23-41
pubmed: 6030463
J Clin Invest. 1981 Nov;68(5):1229-42
pubmed: 7298849

Auteurs

Caroline Ovadia (C)

Division of Women and Children's Health, King's College London, London, United Kingdom.

Alvaro Perdones-Montero (A)

Section of Biomolecular Medicine, Division of Computational & Systems Medicine, Department of Surgery & Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.

Konstantina Spagou (K)

Section of Biomolecular Medicine, Division of Computational & Systems Medicine, Department of Surgery & Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.

Ann Smith (A)

School of Biosciences, Cardiff University, Cardiff, United Kingdom.

Magali H Sarafian (MH)

Section of Biomolecular Medicine, Division of Computational & Systems Medicine, Department of Surgery & Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.

Maria Gomez-Romero (M)

Section of Biomolecular Medicine, Division of Computational & Systems Medicine, Department of Surgery & Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.

Elena Bellafante (E)

Division of Women and Children's Health, King's College London, London, United Kingdom.

Louise C D Clarke (LCD)

Division of Women and Children's Health, King's College London, London, United Kingdom.

Fouzia Sadiq (F)

Division of Digestive Diseases, Hammersmith Hospital, Imperial College London, London, United Kingdom.

Vanya Nikolova (V)

Division of Women and Children's Health, King's College London, London, United Kingdom.

Alice Mitchell (A)

Division of Women and Children's Health, King's College London, London, United Kingdom.

Peter H Dixon (PH)

Division of Women and Children's Health, King's College London, London, United Kingdom.

Natalie Santa-Pinter (N)

Division of Women and Children's Health, King's College London, London, United Kingdom.

Annika Wahlström (A)

Institute of Medicine, Department of Molecular and Clinical Medicine and Wallenberg Laboratory, University of Gothenburg, Gothenburg, Sweden.

Shadi Abu-Hayyeh (S)

Division of Women and Children's Health, King's College London, London, United Kingdom.

Julian R F Walters (JRF)

Division of Digestive Diseases, Hammersmith Hospital, Imperial College London, London, United Kingdom.

Hanns-Ulrich Marschall (HU)

Institute of Medicine, Department of Molecular and Clinical Medicine and Wallenberg Laboratory, University of Gothenburg, Gothenburg, Sweden.

Elaine Holmes (E)

Section of Biomolecular Medicine, Division of Computational & Systems Medicine, Department of Surgery & Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.

Julian R Marchesi (JR)

School of Biosciences, Cardiff University, Cardiff, United Kingdom.
Centre for Digestive and Gut Health, Department of Surgery and Cancer, Imperial College London, London, United Kingdom.

Catherine Williamson (C)

Division of Women and Children's Health, King's College London, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH